Skip to main content

Table 1 Clinical parameters of patients with early-diagnosed Crohn’s disease treated by intensive granulocyte and monocyte adsorptive apheresis combined with thiopurines therapy

From: Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease

Age (years)

39.5 ± 2.9

Sex (men/women)

18/4

Disease duration (months)

5.8 ± 1.8

Disease location

 

      Colon

13 (59.1)

     Colon/Ileum

3 (13.6)

      Ileum

6 (27.3)

Disease behavior

 

     Inflammatory

22 (100)

      Structure

1 (4.5)

     Perforation

0

Perianal disease

2 (9.1)

Previous treatment

 

      5-ASA

5 (22.7)

     Thiopurines

0

    Corticosteroids

0

      Biologics

0

CDAI

260.0 ± 10.5

SES-CD

9.4 ± 0.9

CRP (mg/dl)

3.5 ± 0.7

  1. Number of patients is shown for sex, disease location, disease behavior, perianal disease and previous treatment. Data are presented as mean ± SE for age, disease duration, CDAI, SES-CD, and CRP. 5-ASA 5-aminosalicylate; CDAI, Crohn’s disease activity index; SES-CD, Simple endoscopic score of Crohn’s disease. Values in parenthesis on vertical line are percentages of all 22 patients with early-diagnosed CD.